Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of California, San Francisco |
---|---|
Information provided by: | NIH AIDS Clinical Trials Information Service |
ClinicalTrials.gov Identifier: | NCT00002262 |
To evaluate tolerance, toxicity, and preliminary evidence of antitumor efficacy of intralesionally administered tumor necrosis factor (TNF) and to define a maximum tolerated dose (MTD) for single intralesional injections. In addition, to assess the effects of TNF injections on Kaposi's sarcoma (KS) lesions as measured by P-32 magnetic resonance spectroscopy.
Condition | Intervention | Phase |
---|---|---|
Sarcoma, Kaposi HIV Infections |
Drug: Tumor Necrosis Factor |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Dose Comparison |
Official Title: | A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma |
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Patients must have:
Exclusion Criteria
Co-existing Condition:
Patients with the following conditions or symptoms are excluded:
Concurrent Medication:
Excluded:
Patients with the following are excluded:
Prior Treatment:
Excluded within 4 weeks of study entry:
Study ID Numbers: | 066A, 86-989 |
Study First Received: | November 2, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00002262 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Skin Neoplasms Tumor Necrosis Factor Acquired Immunodeficiency Syndrome |
Sexually Transmitted Diseases, Viral Skin Diseases Acquired Immunodeficiency Syndrome Sarcoma, Kaposi Skin Neoplasms Immunologic Deficiency Syndromes Kaposi Sarcoma Herpesviridae Infections Virus Diseases |
Neoplasms, Connective and Soft Tissue Soft Tissue Sarcomas Malignant Mesenchymal Tumor Necrosis HIV Infections Sexually Transmitted Diseases Sarcoma DNA Virus Infections Retroviridae Infections |
Sexually Transmitted Diseases, Viral Slow Virus Diseases Infection Neoplasms, Connective and Soft Tissue Necrosis Pathologic Processes Neoplasms by Site Neoplasms, Vascular Tissue Retroviridae Infections RNA Virus Infections Neoplasms by Histologic Type Immune System Diseases Skin Diseases |
Sarcoma, Kaposi Acquired Immunodeficiency Syndrome Skin Neoplasms Immunologic Deficiency Syndromes Herpesviridae Infections Virus Diseases Neoplasms HIV Infections Sexually Transmitted Diseases Lentivirus Infections Sarcoma DNA Virus Infections |